NCT03483675View on ClinicalTrials.gov

Discontinuation or Continuation of Immunosuppressive Therapy in Participants With Chronic Graft Versus Host Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 6, 2018

Primary Completion Date

May 14, 2020

Study Completion Date

March 3, 2021

Conditions
Chronic Graft Versus Host Disease
Interventions
BIOLOGICAL

Immunosuppressive Therapy

Discontinued IST

BIOLOGICAL

Immunosuppressive Therapy

Continued IST

OTHER

Survey Administration

Ancillary studies

Trial Locations (1)

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT03483675 - Discontinuation or Continuation of Immunosuppressive Therapy in Participants With Chronic Graft Versus Host Disease | Biotech Hunter | Biotech Hunter